Tetravalent Chimeric Dengue Vaccine Trial
- Conditions
- Dengue
- Interventions
- Drug: Placebo (ID)Drug: Placebo (SC)Biological: Modified Live Tetravalent Chimeric Dengue Vaccine (ID)Biological: Modified Live Tetravalent Chimeric Dengue Vaccine (SC)
- First Posted Date
- 2010-04-26
- Last Posted Date
- 2013-02-04
- Target Recruit Count
- 72
- Registration Number
- NCT01110551
- Locations
- 🇺🇸
Saint Louis University - Center for Vaccine Development, Saint Louis, Missouri, United States
Safety Study of a Human Metapneumovirus Challenge Virus in Healthy Adults
- Conditions
- Human Metapneumovirus
- Interventions
- Biological: HMPV challenge virus
- First Posted Date
- 2010-04-23
- Last Posted Date
- 2013-01-03
- Target Recruit Count
- 21
- Registration Number
- NCT01109329
- Locations
- 🇺🇸
Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States
Extended Follow-Up of Participants in Preventive HIV Vaccine Studies in Uganda
- Conditions
- HIV Infections
- Locations
- 🇺🇬
Makerere University Walter Reed Project (MUWRP), Kampala, Uganda
Evaluating the Safety and Immune Response of an Adenovirus-Based HIV Vaccine in HIV-Uninfected Adults
- Conditions
- HIV Infections
- Interventions
- Biological: Ad26.ENVA.01 (rAd26)Biological: Placebo Vaccine
- First Posted Date
- 2010-04-15
- Last Posted Date
- 2017-09-08
- Target Recruit Count
- 24
- Registration Number
- NCT01103687
- Locations
- 🇺🇸
Brigham and Women's Hosp. Novel Adenoviral Vector Prophylactic HIV Vaccine Non-Network CRS, Boston, Massachusetts, United States
Evaluating Heterologous-Insert Prime-Boost HIV Vaccine Regimens in HIV-Uninfected Adults
- Conditions
- HIV Infections
- Interventions
- Biological: rAd35 Env ABiological: rAd5 Env ABiological: rAd5 Env B
- First Posted Date
- 2010-03-30
- Last Posted Date
- 2021-10-15
- Target Recruit Count
- 180
- Registration Number
- NCT01095224
- Locations
- 🇺🇸
New York Blood Center CRS, New York, New York, United States
🇺🇸Columbia P&S CRS, New York, New York, United States
🇺🇸University of Rochester Vaccines to Prevent HIV Infection CRS, Rochester, New York, United States
Cardiovascular Radiologic and Metabolic Assessment in HIV: An Investigation of Pathophysiology
- Conditions
- Cardiovascular DiseaseHIV
- First Posted Date
- 2010-03-18
- Last Posted Date
- 2018-02-14
- Target Recruit Count
- 168
- Registration Number
- NCT01089114
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Cellular and Humoral Immune Response to Primary and Secondary Immunization With Subvirion H5N1 Vaccines
- Conditions
- Influenza
- Interventions
- Biological: Influenza Virus Vaccine, Monovalent A/H5N1 A/Indonesia/05/2005
- First Posted Date
- 2010-03-15
- Last Posted Date
- 2016-01-01
- Target Recruit Count
- 95
- Registration Number
- NCT01086566
- Locations
- 🇺🇸
University of Rochester Medical Center - Strong Memorial Hospital - Infectious Diseases, Rochester, New York, United States
An Open-Label, Randomized Phase I Study in Healthy Adults of the Safety and Immunogenicity of Prime-Boost Intervals With Monovalent Influenza Subunit Virion (H5N1) Vaccine, A/Indonesia/05/2005 (Sanofi Pasteur, Inc.) Administered Alone or Following Re...
- Conditions
- Influenza A Virus, H5N1 Subtype
- Interventions
- Biological: VRC-AVIDNA036-00-VPBiological: Monovalent Influenza Subunit Virion (Inactive H5N1) Vaccine
- First Posted Date
- 2010-03-15
- Last Posted Date
- 2017-07-02
- Target Recruit Count
- 64
- Registration Number
- NCT01086657
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
- Conditions
- Systemic Sclerosis-Associated PAH
- Interventions
- Biological: RituximabOther: PlaceboDiagnostic Test: CMRI
- First Posted Date
- 2010-03-15
- Last Posted Date
- 2023-02-21
- Target Recruit Count
- 57
- Registration Number
- NCT01086540
- Locations
- 🇺🇸
University of Colorado Health Sciences Center, Aurora, Colorado, United States
🇺🇸University of Minnesota Health Clinics and Surgery Center, Minneapolis, Minnesota, United States
🇺🇸Boston University Medical Center, Boston, Massachusetts, United States
Evaluation of the Safety and Immune Response to an Investigational Dengue Type 1 Vaccine
- Conditions
- Dengue Virus
- Interventions
- Biological: Investigational Vaccine for DEN1Other: Placebo injection
- First Posted Date
- 2010-03-10
- Last Posted Date
- 2013-01-03
- Target Recruit Count
- 18
- Registration Number
- NCT01084291
- Locations
- 🇺🇸
University of Vermont Vaccine Testing Center, Burlington, Vermont, United States
🇺🇸Fletcher Allen Health Care (FAHC) General Clinical Research Center (GCRC), Burlington, Vermont, United States